Target intelligence / Profile preview

RIG-I-like receptor (RLR)

Target
RLR
Molecular classification
Receptor, Pattern recognition receptor, Intracellular receptor
01

Overview

RIG-I-like receptors (RLRs) are a family of intracellular pattern recognition receptors functioning as key sensors for viral RNA within the cytoplasm, essential for the innate immune response to viral infection. The best characterized member, RIG-I (DDX58), detects 5'-triphosphorylated double- or single-stranded RNA from viruses and initiates a signaling cascade via the adaptor MAVS, ultimately inducing transcription of type I interferons and pro-inflammatory cytokines[2][1][3][4][5]. Other members include MDA5, which preferentially binds long dsRNA, and LGP2, which modulates the activity of RIG-I and MDA5. RLR signaling protects against diverse RNA viruses but must be tightly regulated; dysregulation or chronic activation can contribute to autoimmune and autoinflammatory conditions as well as pathology in infection and cancer settings[4][5][1][3].

Other names
Retinoic acid-inducible gene-I-like receptorRetinoic acid-inducible gene I-like receptorRLRRIG-I (DDX58)MDA5LGP2
02

Biological functions

Immune responseAntiviral responseSignal transductionInduction of type I interferon productionInflammation
03

Disease associations

InfectionInflammationAutoimmune diseaseCancer
04

Safety considerations

Immunopathology due to uncontrolled activationrisk of autoinflammatory or autoimmune disease if dysregulated[5][4][1]

Beyond the preview

Go deeper on RIG-I-like receptor (RLR).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RIG-I-like receptor (RLR).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call